Targeted mutagenesis in human iPSCs using CRISPR genome-editing tools.

Area of Science:

• Stem Cell Biology
• Genome Editing
• Molecular Biology

Background:

• CRISPR genome editing has revolutionized mutagenesis studies.
• Human induced pluripotent stem cells (iPSCs) are crucial for studying gene function, disease modeling, and drug development.
• Existing genome editing methods require improved strategies to mitigate side effects.

Purpose of the Study:

• To present novel and efficient strategies for introducing point mutations, insertions, and deletions in human iPSCs.
• To provide step-by-step experimental protocols for these genome editing techniques.
• To demonstrate the application and efficiency of these strategies in human iPSCs and other cell types.

Main Methods:

• Development of novel CRISPR-based strategies for precise gene editing in human iPSCs.
• Incorporation of drug selection for simplified clone screening.
• Generation of both mutant and wild-type control cell lines for comprehensive analysis.

Main Results:

• Demonstrated high efficiency in introducing point mutations, insertions, and deletions in human iPSCs.
• Successfully applied the developed strategies to generate genetically modified iPSC lines.
• Showcased the adaptability of these methods for use in other cell types.

Conclusions:

• The presented strategies offer a robust and efficient approach for genetic manipulation in human iPSCs.
• These methods facilitate advanced disease modeling, drug screening, and therapeutic development.
• The techniques are versatile and applicable beyond iPSCs, broadening their utility in biomedical research.